These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 1696695

  • 1. The natural course of growth hormone-secreting pituitary adenomas after surgery alone--clinical significance of the growth hormone response to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone.
    Mukada K.
    Neurol Med Chir (Tokyo); 1990 Apr; 30(4):251-7. PubMed ID: 1696695
    [Abstract] [Full Text] [Related]

  • 2. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.
    Watanobe H, Tamura T, Sasaki S, Takebe K.
    Neuropeptides; 1993 Dec; 25(6):363-75. PubMed ID: 8127416
    [Abstract] [Full Text] [Related]

  • 3. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
    De Marinis L, Mancini A, Bianchi A, Gentilella R, Valle D, Giampietro A, Zuppi P, Anile C, Maira G, Giustina A.
    Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
    [Abstract] [Full Text] [Related]

  • 4. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma.
    Gil-del-Alamo P, Pettersson KS, Saccomanno K, Spada A, Faglia G, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):661-6. PubMed ID: 7828356
    [Abstract] [Full Text] [Related]

  • 5. Serum alpha-subunit levels in patients with pituitary adenomas.
    Samejima N, Yamada S, Takada K, Sano T, Ozawa Y, Shimizu T, Usui M, Shishiba Y.
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):479-84. PubMed ID: 11318783
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology.
    Yamada S, Aiba T, Sano T, Kovacs K, Shishiba Y, Sawano S, Takada K.
    Neurosurgery; 1993 Jul; 33(1):20-7. PubMed ID: 7689191
    [Abstract] [Full Text] [Related]

  • 7. Abnormal growth hormone release following luteinizing hormone releasing hormone in anorexia nervosa.
    Maeda K, Tanimoto K, Chihara K.
    Jpn J Psychiatry Neurol; 1987 Mar; 41(1):41-5. PubMed ID: 3114526
    [Abstract] [Full Text] [Related]

  • 8. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW, Klijn JG, van Vroonhoven CC, Stefanko SZ.
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [Abstract] [Full Text] [Related]

  • 9. Gene expression study of thyrotropin releasing hormone (TRH) receptor using RT-PCR: relationship to clinical and immunohistochemical phenotypes in a series of human pituitary adenomas.
    Igarashi-Migitaka J, Yamada S, Hara M, Sano T, Ozawa Y, Ohtani-Kaneko R, Hirata K.
    Endocr J; 2003 Aug; 50(4):459-67. PubMed ID: 14599121
    [Abstract] [Full Text] [Related]

  • 10. Abnormal regulation of prolactin secretion after successful surgery for prolactin-secreting pituitary tumours.
    Schlechte JA, Sherman BM.
    Clin Endocrinol (Oxf); 1981 Aug; 15(2):165-74. PubMed ID: 6796301
    [Abstract] [Full Text] [Related]

  • 11. TRH is a tonic secretagogue in growth hormone secreting but not in nonfunctioning pituitary tumors.
    Somjen D, Tordjman K, Greenman Y, Kohen F, Ouaknine GE, Stern N.
    J Endocrinol Invest; 1999 Feb; 22(2):104-8. PubMed ID: 10195376
    [Abstract] [Full Text] [Related]

  • 12. Paradoxical responses of plasma cortisol, adrenocorticotropic hormone and growth hormone to thyrotropin-releasing hormone and luteinizing-hormone-releasing hormone in anorexia nervosa patients.
    Tamai H, Kobayashi N, Fukata S, Hirota Y, Matsubayashi S, Nakagawa T, Okimura MC, Walter RM, Kumagai LF.
    Psychother Psychosom; 1986 Feb; 46(3):147-51. PubMed ID: 2819929
    [Abstract] [Full Text] [Related]

  • 13. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N, Inoue K, Ishibashi M, Murayama Y, Koide Y, Ito K, Yamaji T, Yamashita K.
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [Abstract] [Full Text] [Related]

  • 14. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.
    Joubert D, Benlot C, Lagoguey A, Garnier P, Brandi AM, Gautron JP, Legrand JC, Peillon F.
    J Clin Endocrinol Metab; 1989 Mar; 68(3):572-7. PubMed ID: 2493037
    [Abstract] [Full Text] [Related]

  • 15. Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances.
    Matsukura S, Kakita T, Hirata Y, Yoshimi H, Fukase M.
    J Clin Endocrinol Metab; 1977 Feb; 44(2):392-7. PubMed ID: 190256
    [Abstract] [Full Text] [Related]

  • 16. Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.
    Utsumi A, Hanew K, Sugawara A, Shimizu Y, Murakami O, Ikeda H, Yoshinaga K.
    J Endocrinol Invest; 1992 Mar; 15(3):167-71. PubMed ID: 1624675
    [Abstract] [Full Text] [Related]

  • 17. Differential response to aminergic stimuli and biological behavior of growth hormone secreting pituitary adenomas.
    Fanghanel G, Larraza O, Villalobos M, Fanghanel L, Velasco M, Velasco F.
    Can J Neurol Sci; 1990 Feb; 17(1):78-82. PubMed ID: 2107017
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the results of trans-sphenoidal surgery in acromegaly by assessment of the growth hormone response to thyrotrophin-releasing hormone.
    Faglia G, Paracchi A, Ferrari C, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 1978 May; 8(5):373-80. PubMed ID: 417883
    [Abstract] [Full Text] [Related]

  • 19. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.
    Kim K, Arai K, Sanno N, Teramoto A, Shibasaki T.
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082
    [Abstract] [Full Text] [Related]

  • 20. Early postoperative basal serum GH level and the GH response to TRH in relation to the long-term outcome of surgical treatment for acromegaly: a report on 39 patients.
    Valdemarsson S, Bramnert M, Cronquist S, Elner A, Eneroth CM, Hedner P, Lindvall-Axelsson M, Nordström CH, Strömblad LG.
    J Intern Med; 1991 Jul; 230(1):49-54. PubMed ID: 1906090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.